Ruxolitinib

ATC L01EJ01 · 8 markets · 77 records

Ruxolitinib 8 markets · 77 records Forms

AU 17 records · 9 strengths

20 mgtabletJakavi 20mg tablets also in US·GB·ES +2
15 mgtabletJakavi 20mg tablets also in US·GB·ES +2
5 mgtabletJakavi 20mg tablets also in US·GB·ES +2
10 mgtabletJakavi 20mg tablets also in US·GB·ES +1
26.28 mgtabletARX-RUXOLITINIB ruxolitinib (as mesilate) 10 mg tablet blister pack+2RUXOLITINIB-RJIC ruxolitinib (as mesilate) 20 mg tablet blister pack、RUXOLITINIB-TIH ruxolitinib (as mesilate) 5 mg tablet blister pack unknown
19.71 mgtabletARX-RUXOLITINIB ruxolitinib (as mesilate) 10 mg tablet blister pack+2RUXOLITINIB-RJIC ruxolitinib (as mesilate) 20 mg tablet blister pack、RUXOLITINIB-TIH ruxolitinib (as mesilate) 5 mg tablet blister pack unknown
13.14 mgtabletARX-RUXOLITINIB ruxolitinib (as mesilate) 10 mg tablet blister pack+2RUXOLITINIB-RJIC ruxolitinib (as mesilate) 20 mg tablet blister pack、RUXOLITINIB-TIH ruxolitinib (as mesilate) 5 mg tablet blister pack unknown
6.57 mgtabletARX-RUXOLITINIB ruxolitinib (as mesilate) 10 mg tablet blister pack+2RUXOLITINIB-RJIC ruxolitinib (as mesilate) 20 mg tablet blister pack、RUXOLITINIB-TIH ruxolitinib (as mesilate) 5 mg tablet blister pack unknown

Records without a stated strength · 1 Jakavi 20mg tablets

US 11 records · 11 strengths

20 mgtabletJAKAFI also in AU·GB·ES +2
15 mgtabletJAKAFI also in AU·GB·ES +2
5 mgtabletJAKAFI also in AU·GB·ES +2
10 mgtabletJAKAFI also in AU·GB·ES +1
15 mgtopicalOPZELURA also in GB·ES·TW
55 mgtablet · extended-releaseJAKAFI
44 mgtablet · extended-releaseJAKAFI
33 mgtablet · extended-releaseJAKAFI
25 mgtabletJAKAFI
22 mgtablet · extended-releaseJAKAFI
11 mgtablet · extended-releaseJAKAFI

GB 6 records · 6 strengths

20 mgtabletJakavi 20mg tablets also in AU·US·ES +2
15 mgtabletJakavi 20mg tablets also in AU·US·ES +2
5 mgtabletJakavi 20mg tablets also in AU·US·ES +2
10 mgtabletJakavi 20mg tablets also in AU·US·ES +1
15 mgtopicalOpzelura 15mg/g cream also in US·ES·TW
5 mgliquidJakavi 5mg/ml oral solution

ES 6 records · 6 strengths

20 mgtabletJakavi 20mg tablets also in AU·US·GB +2
15 mgtabletJakavi 20mg tablets also in AU·US·GB +2
5 mgtabletJakavi 20mg tablets also in AU·US·GB +2
10 mgtabletJakavi 20mg tablets also in AU·US·GB +1
15 mgtopicalOPZELURA also in US·GB·TW
5 mg/1 mLliquidJakavi 20mg tablets

CA 5 records · 5 strengths

20 mgtabletJakavi 20mg tablets also in AU·US·GB +2
15 mgtabletJakavi 20mg tablets also in AU·US·GB +2
5 mgtabletJakavi 20mg tablets also in AU·US·GB +2
10 mgtabletJakavi 20mg tablets also in AU·US·GB +1
1.5 %topicalOPZELURA

HK 5 records · 1 strengths

Records without a stated strength · 1 Jakavi 20mg tablets、LUMIRIX CREAM 15MG/G

TW 4 records · 4 strengths

20 mgtabletJakavi 20mg tablets+1捷可衛錠 20毫克 also in AU·US·GB +2
15 mgtabletJakavi 20mg tablets+1捷可衛錠 15毫克 also in AU·US·GB +2
5 mgtabletJakavi 20mg tablets+1捷可衛錠 5毫克 also in AU·US·GB +2
15 mgtopicalLumirix (ruxolitinib) Cream 15 mg/g+1露美瑞乳膏 also in US·GB·ES

EU 3 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Jakavi 20mg tablets、OPZELURA、Ruxolitinib Viatris

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.